Koronarna balon angioplastika i parenteralna antitrombocitna terapija kod intraoperativnog akutnog infarkta miokarda u opštoj hirurgiji: rizici i korist primenjene terapije

  • Vojislava C. Nešković Military Medical Academy, Clinic for Anesthesiology and Critical Care, University of Defence, Faculty of Medicine of the Military Medical Academy
  • Slobodan D. Obradović Military Medical Academy, Clinic for Emergency and Internal Medicine, University of Defence, Faculty of Medicine of the Military Medical Academy
  • Ana V. Popadić Military Medical Academy, Clinic for Anesthesiology and Critical Care
  • Nenad B. Nikolić Military Medical Academy, Clinic for Anesthesiology and Critical Care
  • Dušica Stamenković Military Medical Academy, Clinic for Anesthesiology and Critical Care; University of Defence, Faculty of Medicine of the Military Medical Academy
  • Zoran R. Kostić Military Medical Academy, Clinic for General Surgery; University of Defence, Faculty of Medicine of the Military Medical Academy,
Ključne reči: perioperativni period;, hirurgija digestivnog sistema, procedure;, infarkt miokarda;, angioplastika, balonska;, tirofiban

Sažetak


Uvod. Kardiovaskularne komplikacije predstavljaju jedan od najvažnijih faktora rizika koji utiče na perioperativni morbiditet i ishod lečenja kod bolesnika sa nekardio­hi­rur­škim operacijama. Ovde prikazujemo bolesnika sa intraope­rativnim akutnim infarktom miokarda i elevacijom ST-segmenta (STEMI) koji je nastao tokom abdominalne hirurške intervencije. U njegovom zbrinjavanju urađena je perkutana balon dilatacija i primenjena intravenska anti­trombocitna terapija. Prikaz slučaja. Bolesnik, star 62 go­dine, bez prethodnih kardiovaskularnih tegoba, podvrgnut je hirurškoj intervenciji u abdomenu. Intraoperativno, došlo je do razvoja STEMI. Zbog održavanja naglašene hipo­tenzije (srednji arterijski pritisak od 40 mmHg), operacija je ubrzano završena i bolesnik preveden u jedinicu intenzivnog lečenja. Unutar prvog sata od završetka operacije, urađena je koronarografija i u istom aktu balon angioplastika oklu­di­ra­ne desne koronarne arterije. Uključena je infuzija tirofibana u preporučenoj dozi. Tokom prvih 15 sati, kod bolesnika se održavala hemodinamska nestabilnost usled hipovolemije i ekstenzivne drenaže (1500 mL krvi). Narednog dana, drenaža se održavala (dodatnih 600 mL krvi), što je dovelo do naglašene hipotenzije (65/40 mmHg). Postoperativno, ordinirano je 1970 mL krvi, 6 doza trombocita i 840 mL sveže smrznute plazme. Uprkos naglašenoj hemodinamskoj nestabilnosti i krvarenju, primenjena terapija dovela je do potpunog oporavka. Zaključak. Izbor terapije za bolesnike sa perioperativnim STEMI i dalje predstavlja veliki izazov. Kod hirurških bolesnika, kod kojih postoji visok rizik od krvarenja i tromboze, balon dilatacija bez plasiranja stenta, sa primenom peranteralnih antitrombocitnih lekova može biti dobar terapijski pristup. Potreban je individualizovan pristup lečenju, sa procenom rizika i koristi za svakog bolesnika.

Reference

Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in non-cardiac surgery. N Engl J Med 2001; 345(23): 1677–82.

Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35(35): 2383–431.

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372(9633): 139–44.

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33(20): 2551–67.

Task Force Members. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35(37): 2541–619.

Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569–619.

Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 2011; 154(8): 523–8.

Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Inves¬ti-gators and University of Michigan Heart Care Program. Co-ronary Artery Surgery Study. Circulation 1997; 96(6): 1882–7.

Gordon EK, Fleisher LA. Reducing perioperative cardiac morbidity and mortality: is this the right goal? Curr Opin Crit Care 2013; 19(4): 342–5.

Wang TY, Nallamothu BK, Krumholz HM, Li S, Roe MT, Jollis JG, et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. JAMA 2011; 305(24): 2540–7.

Obal D, Kindgen-Milles D, Schoebel F, Schlack W. Coronary artery angioplasty for treatment of peri-operative myocardial ischaemia. Anaesthesia 2005; 60(2): 194–7.

Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35(5): 1288–94.

Objavljeno
2021/05/21
Rubrika
Prikaz bolesnika